Click Here to Access The Full Article The study, titled “Potent neutralization of SARS-CoV-2 including variants of concern by vaccines presenting the receptor-binding domain multivalently from nanoscaffolds,” investigates a nanoparticle-based vaccine platform targeting SARS-CoV-2 and…
Read More
Blog
Discovery Of PF-06928215 As A High Affinity Inhibitor of cGAS Enabled by a Novel Fluorescence Polarization Assay
Click Here to Access Full Article The study focuses on the development of a high affinity inhibitor for cyclic GMP-AMP synthase (cGAS), an enzyme crucial for innate immune response to cytosolic DNA. The inappropriate activation…
Read More
Sensitive and Specific Immunohistochemistry Protocol for Nucleocapsid Protein from All Common SARS-CoV-2 Virus Strains in Formalin-Fixed, Paraffin Embedded Tissues
Click Here to Access Full Article The study by Yunguang Sun and colleagues presents a robust protocol for detecting SARS-CoV-2 proteins in formalin-fixed, paraffin-embedded (FFPE) tissues. The research aims to enhance the detection of SARS-CoV-2…
Read More
Exploring Single Domain Antibodies for Tauopathy Treatment
Click Here to Access Full Article Researchers at New York University Grossman School of Medicine, led by Erin E. Congdon, have explored the potential of single domain antibodies (sdAbs) in treating tauopathies, including Alzheimer’s disease….
Read More
The Role of Monoclonal Antibodies & Biosimilars in Research
Download the white paper. In 1986, the first monoclonal antibody became licensed as a therapeutic drug–an event occurring nine years after the generation of the first monoclonal antibody (mAb) [1]. The journey of how monoclonal antibodies…
Read More
Our Custom Antibody Services Play a Key Role in Cancer Biomarker Study
ProSci’s custom antibody service played a crucial role in the recent study conducted by the Genome Protection and Roswell Park Comprehensive Cancer Center titled “Cancer relevance of circulating antibodies against LINE-1 antigens in humans ”…
Read More
ProSci’s Custom Antibody Services Support Study Investigating Efficacy of Tau Antibodies
We’re thrilled to announce that Dr. Sigurdsson’s distinguished research team conducted a cutting-edge study on the efficacy and safety profile of sdAbs with the help of our scientists, who provide leading Custom Single Domain (VHH)…
Read More
Does Your Research Require High-Quality and Consistent Rabbit Recombinant Antibodies?
Download the white paper. Recombinant antibodies have revolutionized the field of research, offering a more specific, consistent, and high-quality alternative to traditional antibody development methods. ProSci offers a comprehensive suite of services for recombinant antibody…
Read More
Single Domain Antibodies: Unlocking the Potential of Targeted Therapeutics
Antibodies are an essential immune system component and play a vital role in disease diagnosis and treatment. In recent years, breakthroughs in the development of single-domain antibodies (sdAbs) have opened new possibilities in biotechnology and…
Read More
Enhance your Research with ProSci’s Polyclonal Antibody Services
What are Polyclonal Antibodies? Download the white paper. Polyclonal antibodies are a mixture of antibodies from multiple B-cell clones of a host animal that can recognize multiple epitopes on an antigen. Their unique binding characteristic…
Read More
